GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xiangyu Medical Co Ltd (SHSE:688626) » Definitions » Peter Lynch Fair Value

Xiangyu Medical Co (SHSE:688626) Peter Lynch Fair Value : ¥8.82 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Xiangyu Medical Co Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Xiangyu Medical Co's PEG is 1. Xiangyu Medical Co's 5-Year TTM EBITDA Growth Rate is 6.73. Xiangyu Medical Co's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.31. Therefore, the Peter Lynch Fair Value for today is ¥8.82.

As of today (2024-05-27), Xiangyu Medical Co's share price is ¥36.05. Xiangyu Medical Co's Peter Lynch fair value is ¥8.82. Therefore, Xiangyu Medical Co's Price to Peter Lynch Fair Value Ratio for today is 4.09.


The historical rank and industry rank for Xiangyu Medical Co's Peter Lynch Fair Value or its related term are showing as below:

SHSE:688626' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 3.94   Med: 6.04   Max: 6.04
Current: 4.09


During the past 7 years, the highest Price to Peter Lynch Fair Value Ratio of Xiangyu Medical Co was 6.04. The lowest was 3.94. And the median was 6.04.


SHSE:688626's Price-to-Peter-Lynch-Fair-Value is ranked worse than
83.94% of 193 companies
in the Medical Devices & Instruments industry
Industry Median: 1.7 vs SHSE:688626: 4.09

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Xiangyu Medical Co Peter Lynch Fair Value Historical Data

The historical data trend for Xiangyu Medical Co's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangyu Medical Co Peter Lynch Fair Value Chart

Xiangyu Medical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - 8.82

Xiangyu Medical Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 8.82 -

Competitive Comparison of Xiangyu Medical Co's Peter Lynch Fair Value

For the Medical Devices subindustry, Xiangyu Medical Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xiangyu Medical Co's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xiangyu Medical Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Xiangyu Medical Co's Price-to-Peter-Lynch-Fair-Value falls into.



Xiangyu Medical Co Peter Lynch Fair Value Calculation

Xiangyu Medical Co's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 6.73 *1.31
=8.82

Xiangyu Medical Co's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was ¥1.31.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Xiangyu Medical Co  (SHSE:688626) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 6.73 instead of 15 in this case.

Xiangyu Medical Co's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=36.05/8.82
=4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xiangyu Medical Co Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Xiangyu Medical Co's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiangyu Medical Co (SHSE:688626) Business Description

Traded in Other Exchanges
N/A
Address
Middle Section of Dixu Avenue, Neihuang County, Henan Province, Anyang, CHN, 456300
Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.
Executives
He Yong Zheng Director, core technical staff

Xiangyu Medical Co (SHSE:688626) Headlines

No Headlines